1. Home
  2. SKM vs PRAX Comparison

SKM vs PRAX Comparison

Compare SKM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SK Telecom Co. Ltd.

SKM

SK Telecom Co. Ltd.

HOLD

Current Price

$20.60

Market Cap

7.7B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$289.57

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKM
PRAX
Founded
1984
2015
Country
South Korea
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SKM
PRAX
Price
$20.60
$289.57
Analyst Decision
Hold
Strong Buy
Analyst Count
1
14
Target Price
N/A
$373.79
AVG Volume (30 Days)
670.1K
615.7K
Earning Date
02-11-2026
02-27-2026
Dividend Yield
4.16%
N/A
EPS Growth
N/A
N/A
EPS
1.89
N/A
Revenue
$12,327,044,068.00
$7,463,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.05
$12,467.71
P/E Ratio
$19.37
N/A
Revenue Growth
N/A
364.98
52 Week Low
$19.66
$26.70
52 Week High
$23.80
$317.72

Technical Indicators

Market Signals
Indicator
SKM
PRAX
Relative Strength Index (RSI) 57.38 62.90
Support Level $20.32 $268.78
Resistance Level $20.75 $317.72
Average True Range (ATR) 0.19 13.98
MACD 0.07 -3.34
Stochastic Oscillator 83.49 50.81

Price Performance

Historical Comparison
SKM
PRAX

About SKM SK Telecom Co. Ltd.

SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: